OOIR: Observatory of International Research

Papers

(The H4-Index of Fertility and Sterility is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 500 papers]. The publications cover those that have been published in the past four years, i.e., from 2019-11-01 to 2023-11-01.)

Article	Citations
Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion	349
Preimplantation genetic testing for aneuploidy versus morphology as selection criteria for single frozen-thawed embryo transfer in good-prognosis patients: a multicenter randomized clinical trial	332
No evidence of severe acute respiratory syndrome–coronavirus 2 in semen of males recovering from coronavirus disease 2019	322
Assessment of SARS-CoV-2 in human semen—a cohort study	249
Definitions of infertility and recurrent pregnancy loss: a committee opinion	223
Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues	148
Diagnosis and treatment of infertility in men: AUA/ASRM guideline part I	131
Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers	119
Testing and interpreting measures of ovarian reserve: a committee opinion	107
Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?	107
The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial	104
A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing–based preimplantation genetic testing for	102
Frozen-thawed embryo transfer: the potential importance of the corpus luteum in preventing obstetrical complications	92
ASRM müllerian anomalies classification 2021	87
Rate of true recurrent implantation failure is low: results of three successive frozen euploid single embryo transfers	82
Evidence-based treatments for couples with unexplained infertility: a guideline	81
Relationships between the age of 25,445 men attending infertility clinics and sperm chromatin structure assay (SCSA®) defined sperm DNA and chromatin integrity	80
Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use	78
Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine	77
Evaluation of ovarian tissue transplantation: results from three clinical centers	75
Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion	73
SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle	72
Evaluation of peripheral and uterine immune status of chronic endometritis in patients with recurrent reproductive failure	67
Artificial intelligence in human in vitro fertilization and embryology	67
Importance of patient selection to analyze in vitro fertilization outcome with transplanted cryopreserved ovarian tissue	66

Vitrification of the human embryo: a more efficient and safer in vitro fertilization treatment	65
Oocyte vitrification for fertility preservation in women with endometriosis: an observational study	65
Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II	64
Sperm quality and absence of SARS-CoV-2 RNA in semen after COVID-19 infection: a prospective, observational study and validation of the SpermCOVID test	62
Adverse obstetric and perinatal outcomes in 1,136 singleton pregnancies conceived after programmed frozen embryo transfer (FET) compared with natural cycle FET	60
Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone–antagonist: a randomized clinical trial	59
Intracytoplasmic sperm injection (ICSI) for non–male factor indications: a committee opinion	59
Body-image distress is increased in women with polycystic ovary syndrome and mediates depression and anxiety	54
Fertility evaluation of infertile women: a committee opinion	54
Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss: a systematic review and meta-analysis	53
Cesarean scar defects: management of an iatrogenic pathology whose prevalence has dramatically increased	53
Oocyte vitrification for fertility preservation for both medical and nonmedical reasons	52
In vitro growth and maturation of primordial follicles and immature oocytes	52
Reproductive and oncologic outcomes after fertility-sparing surgery for early stage cervical cancer: a systematic review	52
Endometrium preparation and perinatal outcomes in women undergoing single-blastocyst transfer in frozen cycles	52
The sixth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen: ensuring quality and standardization in basic examination of human ejaculates	51
Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis	50
Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women	49
Consistency and objectivity of automated embryo assessments using deep neural networks	48
Macrophages display proinflammatory phenotypes in the eutopic endometrium of women with endometriosis with relevance to an infectious etiology of the disease	48
A review of the pathophysiology of recurrent implantation failure	47
New insights to guide patient care: the bidirectional relationship between male infertility and male health	47